drug
abelacimab
Phase 3updated 3mo agoby $NVS NOVARTIS AG
Phase 3community read0 votes
indications
indications
Atrial Fibrillation
all catalysts(0)
nothing on the calendar yet
Trials studying abelacimab
- phase3Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- phase3A Study Comparing Abelacimab to Dalteparin in the Treatment of Gastrointestinal/Genitourinary Cancer and Associated VTE
- phase3A Study Comparing Abelacimab to Apixaban in the Treatment of Cancer-associated VTE
- phase2Safety and Tolerability of Abelacimab (MAA868) vs. Rivaroxaban in Patients With Atrial Fibrillation
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 9m ago
Found something off?
comments(0)
5-min edit window · permanent after that